Description
GLP-2 TZ is being compared to other GLP-1 agonists like T*rzepatide (active ingredient in M*unjaro and Z*pbound), which are already approved for type 2 diabetes and/or weight loss. Insulin Secretion: GLP-2 TZ stimulates the pancreas to release insulin in response to high blood sugar levels, helping to lower blood sugar in people with type 2 diabetes. Blood Sugar Control: It also helps regulate blood sugar by signaling the liver to produce less glucose (sugar) and slowing down the rate at which food leaves the stomach. Appetite and Weight Management: GLP-2 TZ targets areas of the brain that regulate appetite and food cravings, helping to decrease appetite and reduce food intake, leading to weight loss. It also helps in weight loss by influencing fat metabolism.
